FIND DOCTORS
-
Name: Wang, Huaying
Department: GYNECOLOGIC ONCOLOGY
Title:MD, PhD, Professor of Gynecologic Oncology ,Doctoral Supervisor,Associate Director of Gynecologic OncologyEducation & Professional Experience 2007 Doctoral supervisor, Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center
2004.6- 2004.12 Visiting scholar, M.D.Anderson Cancer Center
2001.12- Professor, Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center
1993.12-2000.11 Associate Professor, Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center
1990.12-1993.12 Physician, Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center
1985.9-1990.7 MD, Ph.D, Fudan University
1984.8-1990.12 Resident, Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center
Specialty Endometrial Cancer, Cervical Cancer, Ovarian Cancer, Vulvar Cancer and Vaginal Cancer, Gestational Trophoblastic Disease Research Endometrial Cancer (including sarcoma) Publication 1.Yulan Ren, Huaying Wang, Xiaoyan Zhou, et al. Clinicopathological Characteristics and Her-2/neu Status in Chinese Patients with Uterine Papillary Serous Carcinoma, ISRN Obstetrics and Gynecology, Volume 2011 (2011), Article ID 575327
2.Ren Y, Wang H. Advancement of target therapy in endometrial cancer. China Oncology 2010, 20(5): 397-400.
3.Shan B, Wang H, Sun Z, et al. The efficacy of modified radical hysterectomy or radical hysterectomy in local-regional control of stageⅠendometrioid carcinoma. Fudan Univ J Med Sci 2009, 36(6):746-752.
4.Shan B, Sun Z, Wang H, et al. Role of systematic lymphadenectomy in the treatment strategy of endometrial cancer and feasibility study for carrying out the surgery. China Oncology 2009, 19(12):915-919.
5.Shan B, Wang H, Sun Z, et al. Case report- fertility sparing therapy of high-grade endometrioid carcinoma. China Oncology, 2009, 19(11):887-888.
6.Chen Y, Wang H. Adjuvant therapy for patients with early stage endometrioid carcinoma. Chin J Obstet Gynecol 2009,44(3):224-227.
7.Ren Y, Wang H, Shi D, et al. Combined treatment and prognostic factors for stage III and IV endometrial carcinoma. Chin J Obstet Gynecol 2008, 43(7):523-527.
8.Sun Z, Wang H, Chen Y, et al. Clinical analysis of treatment outcome for 559 patients with endometrial carcinoma. China Oncology 2008,18（6）：454-456.
9.Sun Z, Wang H, Yang W. Case report – endometrial carcinoma with evaluated AFP. Chin J Obstet Gynecol 2008, 43(5):400.
10.Zhang Y, Ge Y, Wang H. Pharmacokinetics of consecutive intra-arterial and intravenous infusion of 5-fluorouracil and 4’-0-tetrahydropyranyl adriamycin. Tumor 2008, 28(6):480-484.
11.Zhang Y, Ge Y, Wang H. Comparison of pharmacokinetics of pirarubicin and epirubicin after continuous infusion through ear vein and interna iliac artery of rabbits. Shanghai Med J 2008, 31(12):34-37.
12.Huaying Wang, Jianmin Sun, Hongfen Lu, Daren Shi, Zhouluo Ou, Yulan Ren.Micrometastases detected by cytokeratin 19 in sentinel lymph nodes of patients with cervical cancer. Int J of Gynecol Cancer 2006, 16: 643-648.
13.Wang H, Shen L, Sun Z. Endometrial adenocarcinoma in women 40 years old or younger by treatment with progestins: report of 6 cases and review of the literatures. Chin J Obstet Gynecol 2006, 41(4):237－241.
14.Ren Y, Wang H, Shen L. Clinical and pathologic analysis of 33 cases of uterine papillary serous carcinoma. Chin J Obstet Gynecol 2006,12(41):29－33.
15.Wang H, Zhang M, Wang X, et al. Clinical and basic research of multidisplinary treatment for invasive cervical cancer. J Med Res 2006, 35（7）：47－48.
Awards Shanghai Scientific and Technological Advances Award, third-class prize, 2005
Clinical Achievement Award, Fudan University, 2005
Out-patient Schedule Wednesday and Friday morning
